Lexston Life Sciences Corp
Lexston Mining Corporation engages in the acquisition and exploration of mineral properties in Canada. It holds a 100% interest in the Dory property consisting of four non-surveyed contiguous mineral claims totaling 1,348 hectares located within the Alberni Mining Division of British Columbia. The company is based in Vancouver, Canada.
Lexston Life Sciences Corp (LEXTF) - Total Liabilities
Latest total liabilities as of November 2025: $139.01K USD
Based on the latest financial reports, Lexston Life Sciences Corp (LEXTF) has total liabilities worth $139.01K USD as of November 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lexston Life Sciences Corp - Total Liabilities Trend (2021–2024)
This chart illustrates how Lexston Life Sciences Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lexston Life Sciences Corp Competitors by Total Liabilities
The table below lists competitors of Lexston Life Sciences Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dogwood Therapeutics, Inc.
NASDAQ:DWTX
|
USA | $14.61 Million |
|
Strategic Partners A/S
F:1TB0
|
Germany | €789.00K |
|
AS Ekspress Grupp
F:DYC
|
Germany | €56.51 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Lexston Life Sciences Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lexston Life Sciences Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lexston Life Sciences Corp (2021–2024)
The table below shows the annual total liabilities of Lexston Life Sciences Corp from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-05-31 | $39.87K | +255.75% |
| 2023-05-31 | $11.21K | -85.83% |
| 2022-05-31 | $79.09K | +103.79% |
| 2021-05-31 | $38.81K | -- |